Pharmacological and non-pharmacological intervention for rocuronium-induced withdrawal movement in the Korean population: A meta-analysis of 41 studies including 4,742 subjects
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Choi, G.J. | - |
dc.contributor.author | Lee, S. | - |
dc.contributor.author | Lee, J.H. | - |
dc.contributor.author | Park, S.G. | - |
dc.contributor.author | Kang, H. | - |
dc.date.available | 2019-03-09T00:39:12Z | - |
dc.date.issued | 2014-06 | - |
dc.identifier.issn | 2005-6419 | - |
dc.identifier.issn | 2005-7563 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/cau/handle/2019.sw.cau/13817 | - |
dc.description.abstract | Background: We purposed to systemically review studies investigating the prophylactic effect of both pharmacological and non-pharmacological modalities against rocuronium induced withdrawal movement (RIWM) in the Korean population. Methods: Literature search was performed using MEDLINE, EMBASE, CENTRAL, Koreamed, KMBASE, KISS and RISS up to March 2014. Randomized controlled trials (RCTs) comparing pharmacological and non-pharmacological interventions with placebo aimed for the Korean population were included. Outcome measures were the incidence and severity of RIWM. We conducted subgroup analyses according to each intervention method. Results: Data were analyzed from 41 RCTs totaling 4,742 subjects. The overall incidence of RIWM was about 80% (range 56-100%). Incidence and severity of RIWM were significantly reduced with lidocaine (risk ratio [RR] 0.60, 95% CI 0.49-0.74; standardized mean difference [SMD] -0.74, 95% CI -1.05 to -0.44), opioids (RR 0.28, 95% CI 0.18-0.44; SMD -1.71, 95% CI -2.09 to -1.34) and hypnotics (RR 0.36, 95% CI 0.25-0.52; SMD -2.20, 95% CI -2.62 to -1.79). Regardless of tourniquet use, lidocaine showed a prophylactic effect against incidence and severity of RIWM: tourniquet (RR 0.36, 95% CI 0.21-0.62; SMD -1.51, 95% CI -2.15 to -0.86); non-tourniquet (RR 0.58, 95% CI 0.47-0.71; SMD -0.74, 95% CI -1.05 to -0.44). Dilution and slow injection of rocuronium decreased incidence and severity of RIWM: dilution (RR 0.47, 95% CI 0.39-0.56; SMD -1.64, 95% CI -2.47 to -0.81); slow injection (RR 0.34, 95% CI 0.17-0.70; SMD -2.13, 95% CI -2.74 to -1.51). Conclusions: The greater part of pharmacological and non-pharmacological interventions showed prophylactic effect against the incidence and severity of RIWM in the Korean population. © the Korean Society of Anesthesiologists, 2014. | - |
dc.format.extent | 14 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | Korean Society of Anesthesiologists | - |
dc.title | Pharmacological and non-pharmacological intervention for rocuronium-induced withdrawal movement in the Korean population: A meta-analysis of 41 studies including 4,742 subjects | - |
dc.type | Article | - |
dc.identifier.doi | 10.4097/kjae.2014.66.6.419 | - |
dc.identifier.bibliographicCitation | Korean Journal of Anesthesiology, v.66, no.6, pp 419 - 432 | - |
dc.identifier.kciid | ART001883135 | - |
dc.description.isOpenAccess | Y | - |
dc.identifier.scopusid | 2-s2.0-84904071167 | - |
dc.citation.endPage | 432 | - |
dc.citation.number | 6 | - |
dc.citation.startPage | 419 | - |
dc.citation.title | Korean Journal of Anesthesiology | - |
dc.citation.volume | 66 | - |
dc.type.docType | Article | - |
dc.publisher.location | 대한민국 | - |
dc.subject.keywordAuthor | Anesthesia | - |
dc.subject.keywordAuthor | Injection | - |
dc.subject.keywordAuthor | Meta-analysis | - |
dc.subject.keywordAuthor | Pain | - |
dc.subject.keywordAuthor | Rocuronium | - |
dc.subject.keywordAuthor | Systematic review | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kci | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
84, Heukseok-ro, Dongjak-gu, Seoul, Republic of Korea (06974)02-820-6194
COPYRIGHT 2019 Chung-Ang University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.